Atrás
Precio VISEN Pharmaceuticals (02561.HK)
Gráfico del Precio de Acciones 02561.HK
VISEN PHARMA-B (02561.HK)
VISEN Pharmaceuticals
HK$33.8
-1.51%
$-0.52
Mercado cerrado: Jan 16, 16:00:00 HKT
Estadísticas clave
Cierre Anterior
$34.42
Precio de apertura
$34.32
Rango del día
$33.1 - $34.32
Rango de 52 semanas
$29.06 - $69.15
Volumen
15.6K
Volumen promedio
32.8K
EPS (TTM)
-2.12
Rendimiento de dividendos
--
Cap. de mercado
$3.8B
¿Qué es VISEN PHARMA-B?
VISEN Pharmaceuticals operates as a biopharmaceutical company. The company is headquartered in Suzhou, Jiangsu and currently employs 54 full-time employees. The company went IPO on 2025-03-21. The firm's main products under development include lonapegsomatropin, navepegritide, and palopegteriparatide. The lonapegsomatropin is used to treat growth hormone deficiency in children aged 3 to 17 years old. The navepegritide is a disease repair therapy used to treat children with cartilage dysplasia aged 2 to 10 years old. The palopegteriparatide is a treatment method used to treat adult hypoparathyroidism. The firm is in the late stage of research and development, and its products are close to commercialization.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved
